Expression Data from transNOAH breast cancer trial. These data can be used for evaluation of the clinical utility of the research-based PAM50 subtype predictor in predicting pathological complete res
Expression Data from transNOAH breast cancer trial. These data can be used for evaluation of the clinical utility of the research-based PAM50 subtype predictor in predicting pathological complete res